Poly(2‐Hydroxyethyl Methacrylate) Hydrogel‐Based Microneedles for Metformin Release

Poly(2‐Hydroxyethyl Methacrylate) Hydrogel‐Based Microneedles for Metformin Release

Abstract The release of metformin, a drug used in the treatment of cancer and diabetes, from poly(2‐hydroxyethyl methacrylate), pHEMA, hydrogel‐based microneedle patches is demonstrated in vitro. Tuning the composition of the pHEMA hydrogels enables preparation of robust microneedle patches with mec...

Full description

Bibliographic Details
Main Authors: Manoj B. Sharma, Özlem Kap, Hend A. M. Abdelmohsen, Mark D. Ashton, Garry R. Harper, Melike Firlak, Jasmine E. Aaltonen, Kerry A. Bolland, Ryan Bragg, Sarah Deeley, Ella Francis, Nahin Kazi, Bethany L. Mapley, Vasileios Oikonomou, Amal D. Aljohani, David Cheneler, Volkan Kilic, Nesrin Horzum, John G. Hardy
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Global Challenges
Subjects:
aging
cancer
diabetes
drug delivery
hydrogels
microneedles
Online Access:https://doi.org/10.1002/gch2.202300002

Internet

https://doi.org/10.1002/gch2.202300002

Similar Items